Clinical Research Directory
Browse clinical research sites, groups, and studies.
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
Sponsor: InSightec
Summary
The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).
Official title: Assessment of Safety and Efficacy of ExAblate Blood-Brain Barrier Disruption for the Treatment of Patients With Probable Alzheimer's Disease
Key Details
Gender
All
Age Range
50 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2018-09-28
Completion Date
2030-01
Last Updated
2026-01-09
Healthy Volunteers
No
Conditions
Interventions
Blood Brain Barrier (BBB) Disruption
Focal Ultrasound (FUS) involves the application of acoustic energy at low frequencies from over 1000 individual transducers into distinct targets to induce BBB disruption.
Locations (10)
Delray Medical Center & Florida Atlantic University
Delray Beach, Florida, United States
Broward Health Medical Center & The University of Florida
Fort Lauderdale, Florida, United States
University of Florida Health Shands
Gainesville, Florida, United States
Baptist Health South Florida & Florida International University
Miami, Florida, United States
Advent Health
Orlando, Florida, United States
Tampa General Hospital
Tampa, Florida, United States
Weill Cornell Medicine
New York, New York, United States
The Ohio State University -Wexner Medical Center
Columbus, Ohio, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
West Virginia University Rockefeller Neuroscience Center
Morgantown, West Virginia, United States